IXPANBY Trademark
Trademark Overview
On Tuesday, April 18, 2023, a trademark application was filed for IXPANBY with the United States Patent and Trademark Office. The USPTO has given the IXPANBY trademark a serial number of 97893888. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 2, 2024. This trademark is owned by Adlai Nortye USA INC. The IXPANBY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Medicinal preparations, namely, tablets for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Anti-cancer preparations; biological preparations for the treatment of cancer; Chemico-pharmaceutical preparations for the treatment of cancer
Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer; Pharmaceutical product evaluation; Testing of pharmaceuticals
General Information
| Serial Number | 97893888 |
| Word Mark | IXPANBY |
| Filing Date | Tuesday, April 18, 2023 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 27, 2024 |
Trademark Statements
| Goods and Services | Medicinal preparations, namely, tablets for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Anti-cancer preparations; biological preparations for the treatment of cancer; Chemico-pharmaceutical preparations for the treatment of cancer |
| Goods and Services | Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer; Pharmaceutical product evaluation; Testing of pharmaceuticals |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 12, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 12, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Adlai Nortye USA INC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | North Brunswick, NJ 08902 |
| Party Name | Adlai Nortye USA INC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | North Brunswick, NJ 08902 |
Trademark Events
| Event Date | Event Description |
| Friday, April 21, 2023 | NEW APPLICATION ENTERED |
| Friday, May 12, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 16, 2024 | ASSIGNED TO EXAMINER |
| Friday, January 19, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, January 19, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Friday, January 19, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, January 19, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Friday, January 19, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 7, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 7, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 27, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, March 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 23, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, June 17, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, June 17, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, June 17, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, June 17, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, December 2, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, December 2, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, December 2, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, December 2, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
